News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Prothena Corporation plc - Ordinary Shares
(NQ:
PRTA
)
9.790
-0.240 (-2.39%)
Streaming Delayed Price
Updated: 12:29 PM EDT, Apr 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Prothena Corporation plc - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights
February 20, 2025
From
Prothena Corporation plc
Via
Business Wire
Earnings Scheduled For February 20, 2025
↗
February 20, 2025
Via
Benzinga
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
February 13, 2025
From
Prothena Corporation plc
Via
Business Wire
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings)
↗
February 07, 2025
Via
Benzinga
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
↗
January 28, 2025
Via
Benzinga
Demystifying Prothena Corp: Insights From 6 Analyst Reviews
↗
December 20, 2024
Via
Benzinga
Expert Ratings For Prothena Corp
↗
November 13, 2024
Via
Benzinga
Prothena Announces Board of Directors Update
December 30, 2024
From
Prothena Corporation plc
Via
Business Wire
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
December 20, 2024
Via
Benzinga
Topics
Stocks
Prothena Catapults, Flashing A Bullish Sign, On Promise In Parkinson's Disease
↗
December 19, 2024
The drug technically missed the study's primary goal. But there's still promise it could work in specific patients.
Via
Investor's Business Daily
Roche-Prothena Partnered Mid-Stage Parkinson's Trial Misses Primary Endpoint, But Cling On Signs Of Clinical Benefits
↗
December 19, 2024
Prothena and Roche report Phase 2b PADOVA results on prasinezumab in Parkinson's, showing promising trends and nominal significance in key analyses.
Via
Benzinga
Accenture Posts Upbeat Results, Joins Darden Restaurants, CarMax And Other Big Stocks Moving Higher On Thursday
↗
December 19, 2024
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Earnings Preview For Prothena Corp
↗
November 11, 2024
Via
Benzinga
Breaking Down Prothena Corp: 4 Analysts Share Their Views
↗
October 01, 2024
Via
Benzinga
Roche’s Phase IIb Study of Prasinezumab Missed Primary Endpoint, But Suggests Possible Clinical Benefit in Early-Stage Parkinson’s Disease
December 19, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Third Quarter 2024 Financial Results and Business Highlights
November 12, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Third Quarter 2024 Financial Results on November 12
November 05, 2024
From
Prothena Corporation plc
Via
Business Wire
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
October 28, 2024
Via
Benzinga
Dow Dips 300 Points; Emcore Shares Spike Higher
↗
September 30, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 30, 2024
Via
Benzinga
Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
↗
September 30, 2024
Via
Benzinga
Prothena Announces Leadership Team Updates
September 27, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Participate in Upcoming Healthcare Conferences
August 29, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Prothena Reports Second Quarter 2024 Financial Results and Business Highlights
August 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena to Report Second Quarter 2024 Financial Results on August 8
August 01, 2024
From
Prothena Corporation plc
Via
Business Wire
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
↗
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration
May 28, 2024
From
Prothena Corporation plc
Via
Business Wire
PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024
↗
May 08, 2024
PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
